A61K 31/425
Thiazoles
A61K31/425 (Thiazoles) appears on 5,782 US grants and 9,453 published applications in this corpus.
Search patents in A61K- Granted patents
- 5,782
- Published applications
- 9,453
- Assignees
- 3,241
- Inventors
- 19,152
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 35 | 0 |
| 1977 | 25 | 0 |
| 1978 | 22 | 0 |
| 1979 | 17 | 0 |
| 1980 | 14 | 0 |
| 1981 | 23 | 0 |
| 1982 | 10 | 0 |
| 1983 | 22 | 0 |
| 1984 | 23 | 0 |
| 1985 | 28 | 0 |
| 1986 | 10 | 0 |
| 1987 | 15 | 0 |
| 1988 | 10 | 0 |
| 1989 | 16 | 0 |
| 1990 | 20 | 0 |
| 1991 | 17 | 0 |
| 1992 | 18 | 0 |
| 1993 | 27 | 0 |
| 1994 | 25 | 0 |
| 1995 | 38 | 0 |
| 1996 | 38 | 0 |
| 1997 | 96 | 0 |
| 1998 | 61 | 0 |
| 1999 | 92 | 0 |
| 2000 | 90 | 0 |
| 2001 | 131 | 37 |
| 2002 | 112 | 182 |
| 2003 | 125 | 236 |
| 2004 | 83 | 281 |
| 2005 | 81 | 292 |
| 2006 | 100 | 278 |
| 2007 | 88 | 299 |
| 2008 | 85 | 286 |
| 2009 | 69 | 265 |
| 2010 | 131 | 291 |
| 2011 | 128 | 340 |
| 2012 | 175 | 287 |
| 2013 | 213 | 439 |
| 2014 | 291 | 494 |
| 2015 | 295 | 523 |
| 2016 | 334 | 547 |
| 2017 | 351 | 458 |
| 2018 | 285 | 465 |
| 2019 | 351 | 471 |
| 2020 | 290 | 429 |
| 2021 | 259 | 471 |
| 2022 | 248 | 468 |
| 2023 | 203 | 439 |
| 2024 | 199 | 414 |
| 2025 | 218 | 418 |
| 2026 | 145 | 343 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Injectable formulations in a method for treating pain6 Oct 2026US 12,751,943 B2Pelthos Therapeutics Inc.
- Methods and compositions for treating fungal infections6 Oct 2026US 12,751,944 B2Neoculi Pty Ltd
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Combinatory treatment29 Sep 2026US 12,746,216 B2Arivin Therapeutics Oy
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Guanidinylated Amphiphilic Tobramycin Derivates and B-Lactam/B-Lactamase Inhibitor Combinations for Treatment of Pseudomonas Aeruginosa Infections8 Oct 2026US 2026/0306524 A1
- Combination therapy for bacterial infections comprising zinc-chelator, beta-lactam antibiotic and serine beta-lactamase inhibitor8 Oct 2026US 2026/0306526 A1Adjutec Pharma AS
- Polymer-based therapeutics for inductive browning of fat8 Oct 2026US 2026/0306643 A1Purdue Research Foundation
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension648US 5,674,533 ARecordati S.A., Chemical and Pharmaceutical Company · 1997
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005
- Compositions and methods for administration of pharmacologically active compounds245US 6,537,579 B1American BioScience, Inc. · 2003
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005